Collagenase mutant, gene segment, recombinant plasmid, recombinant expression system and application thereof, and method for preparing collagenase mutant and collagen tripeptide
By efficiently secreting and expressing collagenase mutant KT231 in Streptomyces S. lividansTK24 and cooperating with papaya chymoprotein, the problems of low enzyme activity and high production cost in the existing collagenase production methods are solved, and collagen tripeptide is efficiently prepared, suitable for a variety of skin and joint health products.
Patent Information
- Application Number
- CN202510292428.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-03-12
- Publication Date
- 2025-04-08
- Estimated Expiration
- 2045-03-12
AI Technical Summary
The existing collagenase production methods have complex processes, high costs and potential disease transmission risks, and microbial fermentation methods face the problems of low enzyme activity and high production costs in practical applications.
A collagenase mutant KT231 that achieves efficient secretion and expression in Streptomyces S. lividansTK24 was developed, and the proportion of collagen tripeptides in the fish skin enzymatic solution was increased through complexing with commercially available papaya chymoproteinase.
Collagenase mutant KT231 is highly effective in enzymatic decomposition of cod fish skin at 60°C. It has excellent heat resistance and high enzyme activity, which significantly increases the proportion of collagen tripeptide in the enzymatic decomposition of fish skin, and has no bitter taste. It is suitable for the preparation of anti-wrinkle moisturizing, repairing damaged skin and other products.